Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	3.672103078721949e-05	100.81761006289308	-216.95395722754864	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	4.1436292728335544e-05	73.01369863013699	-170.21630123625883	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	4.1436292728335544e-05	74.03703703703704	-172.05130589538587	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	9.613948341558695e-05	54.21768707482993	-134.5540755438832	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.00024889256120237	39.774436090225564	-104.03256013781805	IL1B;MEFV;TLR4;TNF
KEGG_2021_Human	Malaria	3/50	2.5974439121209737e-05	0.00032027142186606065	73.13981762917933	-125.1475077148889	IL1B;TLR4;TNF
KEGG_2021_Human	Necroptosis	4/159	2.7677777198301538e-05	0.00032027142186606065	34.034408602150535	-90.91492941118791	HMGB1;IL1B;TLR4;TNF
KEGG_2021_Human	Tuberculosis	4/180	4.508970382755845e-05	0.0004147279911409746	29.893939393939394	-81.02434645013932	C3;IL1B;TLR4;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	4.608088790455273e-05	0.0004147279911409746	29.721280602636536	-80.60331713278154	IL1B;MEFV;TLR4;TNF
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.00046431027985701994	55.34101382488479	-100.98537671170521	IL1B;TLR4;TNF
KEGG_2021_Human	Coronavirus disease	4/232	0.00012150057084905025	0.0008946860217066428	22.923976608187136	-63.412309433922275	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0010295165775303663	21.55922865013774	-59.801482853342776	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0010418412018937042	37.99047619047619	-74.4091590745228	IL1B;TLR4;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	3/104	0.0002329673917108638	0.001179397420536248	33.806223479490804	-67.40758155759835	IL1B;TLR4;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	3/104	0.0002329673917108638	0.001179397420536248	33.806223479490804	-67.40758155759835	IL1B;TLR4;TNF
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.001179397420536248	34.497835497835496	-68.58379435140506	IL1B;TLR4;TNF
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.004277162190397078	57.378571428571426	-64.24352876962546	IL1B;TNF
KEGG_2021_Human	Influenza A	3/172	0.001019644326496313	0.004588399469233408	20.0312764158918	-42.078889135072146	IL1B;TLR4;TNF
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.0049098264451132075	48.94512195121951	-56.84526782917664	IL1B;TNF
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.0049098264451132075	50.175	-57.95352918467438	IL1B;TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.005168372413857447	18.161290322580644	-38.30003183551744	C3;HMGB1;TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.00556112843669084	17.394698085419734	-36.72187076283526	IL1B;TLR4;TNF
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.006842141716675154	15.881401617250674	-33.55383703082171	IL1B;TLR4;TNF
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.009979327246627069	13.627177700348431	-28.69609856443984	IL1B;TLR4;TNF
KEGG_2021_Human	Complement and coagulation cascades	2/85	0.004661598778005346	0.015103580040737323	24.051204819277107	-31.541623523071053	C3;CFH
KEGG_2021_Human	Staphylococcus aureus infection	2/95	0.005791844483948442	0.017375533451845327	21.438172043010752	-28.45964210186145	C3;CFH
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.017375533451845327	21.67391304347826	-28.742216935482162	IL1B;TNF
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.017875242601099527	20.54381443298969	-27.37901341152302	IL1B;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.017875242601099527	20.331632653061224	-27.120602948412195	IL1B;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.018647278456048955	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.020181798647270023	18.086363636363636	-24.33571316400054	TLR4;TNF
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.020181798647270023	18.086363636363636	-24.33571316400054	IL1B;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.02494143241698903	15.886	-21.510038502238015	IL1B;TNF
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.027189794460762657	14.472627737226277	-19.639406588988233	IL1B;TLR4
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.027189794460762657	14.915413533834586	-20.230385574789178	C3;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.027189794460762657	14.472627737226277	-19.639406588988233	IL1B;TNF
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.0313833519921564	13.196666666666667	-17.909946150058477	C3;TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.03171667132521178	12.933006535947712	-17.54750234216727	IL1B;TNF
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.033611220770041944	12.35625	-16.748364182562245	TLR4;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.04085407234866178	6.556709956709956	-12.239051897711217	C3;IL1B;TNF
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.04982585054771169	9.685960591133005	-12.928804077098514	TLR4;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	2/212	0.026851997557997137	0.051785995290423055	9.354761904761904	-12.440530405951861	TLR4;TNF
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.05650281306349499	8.794843049327355	-11.607417281005194	IL1B;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.0694768699344648	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Base excision repair	1/33	0.040130782413471976	0.07223540834424955	27.90277777777778	-15.299431750604054	HMGB1
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.07538562565994648	7.192804428044281	-9.169844698845731	IL1B;TNF
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.07941976309271173	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.08146400787515477	6.657534246575342	-8.337786615237395	IL1B;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.08146400787515477	6.6339590443686	-8.300944532041967	IL1B;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.0899710169565034	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.11668905328802884	5.2459128065395095	-6.1057863985118	IL1B;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.11737087799243613	14.347670250896057	-8.574814690072902	IL1B
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.12282191450503478	12.880837359098228	-7.74542097629872	TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.12282191450503478	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.12282191450503478	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.13382141872316772	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.14809981091208452	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.14809981091208452	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.15019555755625033	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.15019555755625033	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.15019555755625033	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.15019555755625033	4.014270613107822	-4.131104230952899	IL1B;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.15066177935703873	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.15365293886215617	8.189300411522634	-4.893732148578802	TLR4
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.15365293886215617	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.15365293886215617	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.15365293886215617	8.345911949685535	-4.994589105830365	IL1B
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.1643750437037886	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.17715520902458087	6.7846153846153845	-3.968927686510734	TNF
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.1820214762483617	6.480392156862745	-3.763669230249352	HMGB1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.1854973980983608	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.19707762505881513	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.1978389556965595	5.635327635327635	-3.183908163692195	TNF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.2352397628948222	4.55787037037037	-2.4244944960200487	C3
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.23960667493046586	4.3488114980652295	-2.274707784911856	TNF
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.23960667493046586	4.326732673267327	-2.2588473265567357	C3
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.25292147961426054	4.001019367991845	-2.0240281738454993	TNF
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.3552046224695644	2.6053872053872054	-1.0106876845884132	TNF
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.35937094826733906	2.5254901960784313	-0.9533164047874388	C3
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.3658515730716156	2.4283915643689014	-0.883914601009246	TLR4
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
